Literature DB >> 17327597

Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Cecile Le Péchoux, Ariane Dunant, Jean-Pierre Pignon, Dirk De Ruysscher, Françoise Mornex, Suresh Senan, Francesc Casas, Allan Price, Bernard Milleron.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17327597     DOI： 10.1200/JCO.2006.09.6263

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  A closer look at the safety and effectiveness of modern PORT in stage III-N2 non-small cell lung cancer.

Authors:  Charlotte Billiet; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Tri-modality treatment in N2 stage IIIa non-small cell lung cancer: proper sequence remains unknown.

Authors:  Ze-Rui Zhao; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.

Authors:  Honghai Dai; Zhouguang Hui; Wei Ji; Jun Liang; Jima Lu; Guangfei Ou; Zongmei Zhou; Qinfu Feng; Zefen Xiao; Dongfu Chen; Hongxing Zhang; Weibo Yin; Jie He; Luhua Wang
Journal:  Oncologist       Date:  2011-04-11

4.  Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.

Authors:  Ugur Selek; Joe Y Chang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 5.  Adjuvant therapy in non-small cell lung cancer: current and future directions.

Authors:  Randeep Sangha; Julie Price; Charles A Butts
Journal:  Oncologist       Date:  2010-08-03

6.  What is the optimal adjuvant therapy for T3N0 lung cancer invading the chest wall?

Authors:  Makoto Suzuki; Takeshi Mori; Kenji Shiraishi; Koei Ikeda; Yoshiko Masuda; Eri Matsubara; Chika Shirakami; Hironori Hinokuma
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

7.  Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.

Authors:  Yujin Xu; Jianqiang Li; Jin Wang; Xiao Hu; Honglian Ma; Pu Li; Xiao Zheng; Ming Chen
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 8.  Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.

Authors:  Cécile Le Péchoux
Journal:  Oncologist       Date:  2011-03-04

9.  Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Authors:  John L Mikell; Theresa W Gillespie; William A Hall; Dana C Nickleach; Yuan Liu; Joseph Lipscomb; Suresh S Ramalingam; Raj S Rajpara; Seth D Force; Felix G Fernandez; Taofeek K Owonikoko; Rathi N Pillai; Fadlo R Khuri; Walter J Curran; Kristin A Higgins
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

Review 10.  Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

Authors:  Annemarie Fernandes Shepherd
Journal:  Transl Lung Cancer Res       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.